معرفی
David Geller is an Associate Professor of Medicine in the Nephrology section at Yale School of Medicine. His work focuses on the intersection of nephrology, hypertension, and endocrinology, particularly examining the role of mineralocorticoid receptors in blood pressure regulation and renal function.
- BA, Dartmouth College (1986)
- MD and PhD, New York University (1993)
- Residency, Yale-New Haven Hospital (1996)
- Fellowship, Yale University School of Medicine (1999)
Dr. Geller's research primarily investigates the molecular mechanisms underlying hypertension and renal disorders, with a particular focus on mineralocorticoid receptor function. His work has significantly contributed to understanding how genetic mutations in the mineralocorticoid receptor lead to disorders of blood pressure regulation, including conditions like familial hyperaldosteronism and pseudohypoaldosteronism. His research bridges basic science with clinical applications, examining how these molecular pathways affect patient care, particularly in specialized populations such as pregnant women with hypertension.
Dr. Geller's publication record demonstrates a consistent focus on mineralocorticoid receptor biology and its clinical implications. His work spans from basic molecular mechanisms to clinical applications, with particular emphasis on genetic disorders affecting blood pressure regulation. Over his career, he has contributed to understanding how receptor mutations lead to human disease, how these pathways function in salt-sensitive hypertension, and how they manifest in specialized clinical scenarios like pregnancy.
- Young Investigator Award, International Aldosterone Conference (2001)
- Travel Grant Award, Endocrine Society (2000)
- Top Research Advance in Heart Disease and Stroke, American Heart Association (1999)
Dr. Geller serves on multiple committees including the Intern Selection Committee (since 2004), as Co-Director of the Homeostasis Course (since 2014), and on the Veterans Affairs West Haven Water Safety committee. He previously directed the Renal Module (2013-2015) and served as an ad-hoc member for NIH's Clinical and Integrative Cardiovascular Science study section (2004-2005). His work with veterans' health, particularly regarding hemodialysis transition, demonstrates his commitment to addressing healthcare disparities in vulnerable populations.
